completed seed round. Initiating Series A $10M-$15M. Prioritizing lead therapeutic candidate for cancer and acute viral infections.
This is where a company's traction statement would be visible. As you are not logged in, you cannot see it. When you become an advisor you'll be able to view the traction.
Cytovia Therapeutics is a new biotech company formed in 2019 to build a portfolio of products to harness the power of Natural Killer (NK) Cells in the treatment of cancer and viral infections. Our core technologies are gene edited CAR NK cells produced from stem cells (iPSCs) and NK engager multi-specific antibodies.
Fundraising: pitching, angels and VC rounds; grants & government funding; deal terms
This is where you can find what a company would like mentoring on. The field will become available when you are onboarded.
3
